{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T01:52:00Z","timestamp":1792547520452,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-026-04698-1","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T06:12:44Z","timestamp":1783923164000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Pre- and post-operative metabolic profile of patients with pheochromocytoma: A retrospective multicenter study"],"prefix":"10.1007","volume":"91","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1895-5898","authenticated-orcid":false,"given":"Eleftheria","family":"Kakargia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aikaterini Themis","family":"Vyllioti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia E","family":"Markatseli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stelios","family":"Tigas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Kostopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7345-7912","authenticated-orcid":false,"given":"Zoe A.","family":"Efstathiadou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Foteini","family":"Adamidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nektarios","family":"Adamopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Bargiota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Angelousi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Kaltsas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios","family":"Fountas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irini","family":"Giagourta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athina","family":"Markou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8587-7797","authenticated-orcid":false,"given":"Labrini","family":"Papanastasiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,13]]},"reference":[{"key":"4698_CR1","doi-asserted-by":"crossref","unstructured":"C.M. Beard, S.G. Sheps, L.T. Kurland, J.A. Carney, J.T. Lie, Occurrence of pheochromocytoma in Rochester, Minnesota, 1950 through 1979. Mayo Clin Proc. 1983;58(12):802-4 PMID: 6645626","DOI":"10.1016\/S0025-6196(25)18873-3"},{"issue":"4","key":"4698_CR2","doi-asserted-by":"publisher","first-page":"315","DOI":"10.7326\/0003-4819-134-4-200102200-00016","volume":"134","author":"K Pacak","year":"2001","unstructured":"K. Pacak, W.M. Linehan, G. Eisenhofer, M.M. Walther, D.S. Goldstein, Recent advances in genetics, diagnosis, localization, and treatment of pheochromocytoma. Ann. Intern. Med. 134(4), 315\u2013 (2001). \u2013\u200929 https:\/\/doi.org\/10.7326\/0003-4819-134-4-200102200-00016","journal-title":"Ann. Intern. Med."},{"issue":"1","key":"4698_CR3","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1097\/00005792-199101000-00004","volume":"70","author":"PP Stein","year":"1991","unstructured":"P.P. Stein, H.R. Black, A simplified diagnostic approach to pheochromocytoma. A review of the literature and report of one institution\u2019s experience. Med. (Baltim). 70(1), 46\u201366 (1991). : 101097\/00005792-199101000-00004 PMID: 1988766","journal-title":"Med. (Baltim)."},{"issue":"11","key":"4698_CR4","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/S2213-8587(20)30314-4","volume":"8","author":"A Ebbehoj","year":"2020","unstructured":"A. Ebbehoj, D. Li, R.J. Kaur, C. Zhang, S. Singh, T. Li et al., Epidemiology of adrenal tumours in Olmsted County, Minnesota, USA: a population-based cohort study. Lancet Diabetes Endocrinol. 8(11), 894\u2013902 (2020). https:\/\/doi.org\/10.1016\/S2213-8587(20)30314-4","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"1","key":"4698_CR5","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1093\/ejendo\/lvad066","volume":"189","author":"M Fassnacht","year":"2023","unstructured":"M. Fassnacht, S. Tsagarakis, M. Terzolo, A. Tabarin, A. Sahdev, J. Newell-Price et al., European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors. Eur. J. Endocrinol. 189(1), G1\u201342 (2023). https:\/\/doi.org\/10.1093\/ejendo\/lvad066","journal-title":"Eur. J. Endocrinol."},{"issue":"8","key":"4698_CR6","doi-asserted-by":"publisher","first-page":"870","DOI":"10.4158\/EP15618.OR","volume":"21","author":"J Patrova","year":"2015","unstructured":"J. Patrova, I. Jarocka, H. Wahrenberg, H. Falhammar, Clinical Outcomes in Adrenal Incidentaloma: Experience From one Center. Endocr. Pract. 21(8), 870\u2013877 (2015). https:\/\/doi.org\/10.4158\/EP15618.OR","journal-title":"Endocr. Pract."},{"issue":"12","key":"4698_CR7","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1016\/j.eprac.2022.09.003","volume":"28","author":"K Pacak","year":"2022","unstructured":"K. Pacak, New Biology of Pheochromocytoma and Paraganglioma. Endocr. Pract. 28(12), 1253\u20131269 (2022). https:\/\/doi.org\/10.1016\/j.eprac.2022.09.003","journal-title":"Endocr. Pract."},{"issue":"6","key":"4698_CR8","doi-asserted-by":"publisher","first-page":"5153","DOI":"10.3390\/ijms24065153","volume":"24","author":"C Lopez","year":"2023","unstructured":"C. Lopez, C. Bima, M. Bollati, F. Bioletto, M. Procopio, S. Arata et al., Pathophysiology and Management of Glycemic Alterations before and after Surgery for Pheochromocytoma and Paraganglioma. IJMS. 24(6), 5153 (2023). https:\/\/doi.org\/10.3390\/ijms24065153","journal-title":"IJMS"},{"issue":"3","key":"4698_CR9","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.eprac.2024.11.004","volume":"31","author":"W Zhang","year":"2025","unstructured":"W. Zhang, J. Yu, Y. Chen, Y. Zhou, Y. Cui, T. Li, Y. Wang, W. Ren, A. Tong, Y. Li, Glucose Disorders in Patients With Pheochromocytoma\/Paraganglioma: Profile and Influence Effects in a Large Cohort With 705 Patients. Endocr. Pract. 31(3), 269\u2013277 (2025). https:\/\/doi.org\/10.1016\/j.eprac202411004","journal-title":"Endocr. Pract."},{"issue":"1","key":"4698_CR10","doi-asserted-by":"publisher","first-page":"2203945","DOI":"10.1080\/07853890.2023.2203945","volume":"55","author":"L Zhao","year":"2023","unstructured":"L. Zhao, T. Zhang, X. Meng, Z. Zhang, Y. Zhou, H. Fan et al., Factors contributing to development and resolution of dysglycemia in patients with pheochromocytomas and catecholamine-secreting paragangliomas. Ann. Med. 55(1), 2203945 (2023). https:\/\/doi.org\/10.1080\/07853890.2023.2203945","journal-title":"Ann. Med."},{"issue":"2","key":"4698_CR11","doi-asserted-by":"publisher","first-page":"190","DOI":"10.15386\/mpr-2741","volume":"98","author":"FZ Bentebbaa","year":"2024","unstructured":"F.Z. Bentebbaa, I. Rami, I. Assarrar, R. Elamel, L. Boutaybi, S. Rouf et al., Evolution of metabolic disorders after resection of pheochromocytomas and paragangliomas: a single-center study. Med. Pharm. Rep. 98(2), 190\u2013195 (2024). https:\/\/doi.org\/10.15386\/mpr-2741","journal-title":"Med. Pharm. Rep."},{"issue":"2","key":"4698_CR12","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s12020-025-04277-w","volume":"89","author":"W Zhang","year":"2025","unstructured":"W. Zhang, Y. Zhou, Y. Cui, J. Yu, T. Li, K. Feng, W. Ren, A. Tong, Y. Li, An in-depth exploration of the catecholamine and dyslipidemia relationship in pheochromocytoma and paraganglioma patients: a large Chinese cohort study. Endocrine. 89(2), 595\u2013602 (2025). https:\/\/doi.org\/10.1007\/s12020-025-04277-w","journal-title":"Endocrine"},{"key":"4698_CR13","doi-asserted-by":"publisher","first-page":"1087506","DOI":"10.3389\/fendo.2023.1087506","volume":"14","author":"L Zhao","year":"2023","unstructured":"L. Zhao, Z. Li, X. Meng, H. Fan, Z. Zhang, Z. Zhang et al., Clinical differences between small and large pheochromocytomas and paragangliomas. Front. Endocrinol. 14, 1087506 (2023). https:\/\/doi.org\/10.3389\/fendo.2023.1087506","journal-title":"Front. Endocrinol."},{"issue":"9","key":"4698_CR14","doi-asserted-by":"publisher","first-page":"e2966","DOI":"10.1210\/clinem\/dgae901","volume":"110","author":"A Fischer","year":"2025","unstructured":"A. Fischer, H. Remde, C. Pamporaki, U. Dischinger, N. Bechmann, M. Robledo et al., Long-Term Persistence of Glycemic Dysregulation in Patients With a History of Pheochromocytoma\/Paraganglioma. J. Clin. Endocrinol. Metabolism. 110(9), e2966\u2013e2976 (2025). https:\/\/doi.org\/10.1210\/clinem\/dgae901","journal-title":"J. Clin. Endocrinol. Metabolism"},{"key":"4698_CR15","unstructured":"Obesity, preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 2000;894:i-xii, 1-253 PMID: 11234459"},{"key":"4698_CR16","doi-asserted-by":"publisher","unstructured":"D.W. Writing Committee Members*, Jones, K.C. Ferdinand, S.J. Taler, H.M. Johnson, D. Shimbo, AHA\/ACC\/AANP\/AAPA\/ABC\/ACCP\/ACPM\/AGS\/AMA\/ASPC et al., \/NMA\/PCNA\/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2025;152(11). https:\/\/doi.org\/10.1161\/CIR.0000000000001356","DOI":"10.1161\/CIR.0000000000001356"},{"issue":"1","key":"4698_CR17","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","volume":"41","author":"F Mach","year":"2020","unstructured":"F. Mach, C. Baigent, A.L. Catapano, K.C. Koskinas, M. Casula, L. Badimon et al., 2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur. Heart J. 41(1), 111\u2013188 (2020). https:\/\/doi.org\/10.1093\/eurheartj\/ehz455","journal-title":"Eur. Heart J."},{"issue":"2","key":"4698_CR18","first-page":"69","volume":"38","author":"G Eisenhofer","year":"2017","unstructured":"G. Eisenhofer, B. Klink, S. Richter, J.W. Lenders, M. Robledo, Metabologenomics of Phaeochromocytoma and Paraganglioma: An Integrated Approach for Personalised Biochemical and Genetic Testing. Clin. Biochem. Rev. 38(2), 69\u2013100 (2017).","journal-title":"Clin. Biochem. Rev."},{"issue":"5","key":"4698_CR19","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1530\/EJE-09-0996","volume":"162","author":"E Grouzmann","year":"2010","unstructured":"E. Grouzmann, L. Drouard-Troalen, E. Baudin, P.F. Plouin, B. Muller, D. Grand, T. Buclin, Diagnostic accuracy of free and total metanephrines in plasma and fractionated metanephrines in urine of patients with pheochromocytoma. Eur. J. Endocrinol. 162(5), 951\u2013960 (2010). https:\/\/doi.org\/10.1530\/EJE-09-0996","journal-title":"Eur. J. Endocrinol."},{"issue":"1","key":"4698_CR20","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ando.2020.01.001","volume":"81","author":"A Elenkova","year":"2020","unstructured":"A. Elenkova, J. Matrozova, V. Vasilev, R. Robeva, S. Zacharieva, Prevalence and progression of carbohydrate disorders in patients with pheochromocytoma\/paraganglioma: retrospective single-center study. Ann. Endocrinol. (Paris). 81(1), 3\u201310 (2020). https:\/\/doi.org\/10.1016\/j.ando202001001","journal-title":"Ann. Endocrinol. (Paris)"},{"issue":"4","key":"4698_CR21","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1530\/acta01060511","volume":"106","author":"G Stenstr\u00f6m","year":"1984","unstructured":"G. Stenstr\u00f6m, L. Sj\u00f6str\u00f6m, U. Smith, Diabetes mellitus in phaeochromocytoma. Fasting blood glucose levels before and after surgery in 60 patients with phaeochromocytoma. Acta Endocrinol. (Copenh). 106(4), 511\u2013515 (1984). https:\/\/doi.org\/10.1530\/acta01060511","journal-title":"Acta Endocrinol. (Copenh)"},{"issue":"9","key":"4698_CR22","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1097\/00004872-200309000-00020","volume":"21","author":"A La Batide-Alanore","year":"2003","unstructured":"La A. Batide-Alanore, G. Chatellier, P.F. Plouin, Diabetes as a marker of pheochromocytoma in hypertensive patients. J. Hypertens. 21(9), 1703\u20131707 (2003). https:\/\/doi.org\/10.1097\/00004872-200309000-00020","journal-title":"J. Hypertens."},{"issue":"6","key":"4698_CR23","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1530\/EJE-19-0589","volume":"181","author":"M Zoran Erlic","year":"2019","unstructured":"M. Zoran Erlic, T. Kurlbaum, S. Deutschbein, A. N\u00f6lting, H. Prejbisz, S. Timmers, C. Richter, D. Prehn, J. Weismann, A. Adamski, M. Januszewicz, M. Reincke, M. Fassnacht, G. Robledo, Eisenhofer, Felix Beuschlein, Matthias Kroiss. Metabolic impact of pheochromocytoma\/paraganglioma: targeted metabolomics in patients before and after tumor removal. Eur. J. Endocrinol. 181(6), 647\u2013657 (2019). https:\/\/doi.org\/10.1530\/EJE-19-0589","journal-title":"Eur. J. Endocrinol."},{"issue":"12","key":"4698_CR24","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/j.asjsur.2019.01.012","volume":"42","author":"ZH Liu","year":"2019","unstructured":"Z.H. Liu, L. Zhou, L.D. Lin, T. Chen, Q.Y. Jiang, Z.H. Liu, K.J. Wang, Y.C. Zhu, H. Li, Y. Ren, Will the resection of pheochromocytoma improve preoperative diabetes mellitus? Asian J. Surg. 42(12), 990\u2013994 (2019). https:\/\/doi.org\/10.1016\/j.asjsur201901012","journal-title":"Asian J. Surg."},{"issue":"1","key":"4698_CR25","doi-asserted-by":"publisher","first-page":"42","DOI":"10.4103\/aam.aam_13_20","volume":"20","author":"S Derrou","year":"2021","unstructured":"S. Derrou, T. Bouziane, H. Salhi, E.H. Ouahabi, Pheochromocytoma and glucoregulation disorders. Ann. Afr. Med. 20(1), 42\u201345 (2021). 104103\/aam.aam_13_20 https:\/\/doi.org\/10.4103\/aam.aam_13_20","journal-title":"Ann. Afr. Med."},{"issue":"11","key":"4698_CR26","doi-asserted-by":"publisher","first-page":"e3719","DOI":"10.1210\/clinem\/dgaf154","volume":"110","author":"M Araujo-Castro","year":"2025","unstructured":"M. Araujo-Castro, A. Herrera, Y. Wang, Z. Wang, M. \u015aledzi\u0144ski, A. Hellmann et al., Postoperative Outcomes in Normotensive and Hypertensive Pheochromocytomas: An International Study. J. Clin. Endocrinol. Metabolism. 110(11), e3719\u2013e3729 (2025). https:\/\/doi.org\/10.1210\/clinem\/dgaf154","journal-title":"J. Clin. Endocrinol. Metabolism"},{"issue":"2","key":"4698_CR27","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1007\/s00268-019-05175-9","volume":"44","author":"ML Good","year":"2020","unstructured":"M.L. Good, P. Malekzadeh, S.M. Ruff, S. Gupta, A. Copeland, K. Pacak et al., Surgical Resection of Pheochromocytomas and Paragangliomas is Associated with Lower Cholesterol Levels. World j. surg. 44(2), 552\u2013560 (2020). https:\/\/doi.org\/10.1007\/s00268-019-05175-9","journal-title":"World j. surg."},{"issue":"2","key":"4698_CR28","doi-asserted-by":"publisher","first-page":"251","DOI":"10.7326\/0003-4819-71-2-251","volume":"71","author":"JA Colwell","year":"1969","unstructured":"J.A. Colwell, Inhibition of insulin secretion by catecholamines in pheochromocytoma. Ann. Intern. Med. 71(2), 251\u2013256 (1969). https:\/\/doi.org\/10.7326\/0003-4819-71-2-251","journal-title":"Ann. Intern. Med."},{"issue":"6","key":"4698_CR29","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1016\/j.dsx.2020.10.030","volume":"14","author":"S Khatiwada","year":"2020","unstructured":"S. Khatiwada, S. Agarwal, D. Kandasamy, V.P. Jyotsna, R. Kumar, V. Kumar Bansal, R.M. Pandey, N. Gupta, N. Tandon, Diabetes mellitus in pheochromocytoma and paraganglioma: Prevalence, dynamics of insulin secretion \/ sensitivity and predictors of remission. Diabetes Metab. Syndr. 14(6):2169\u20132175 (2020). 101016\/j.dsx202010030 https:\/\/doi.org\/10.1016\/j.dsx202010030","journal-title":"Diabetes Metab. Syndr."},{"issue":"4","key":"4698_CR30","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1530\/EJE-19-0159","volume":"181","author":"A Geroula","year":"2019","unstructured":"A. Geroula, T. Deutschbein, K. Langton, J. Masjkur, C. Pamporaki, M. Peitzsch, S. Fliedner, H.J.L.M. Timmers, S.R. Bornstein, F. Beuschlein, A. Stell, A. Januszewicz, A. Prejbisz, M. Fassnacht, J.W.M. Lenders, G. Eisenhofer, Pheochromocytoma and paraganglioma: clinical feature-based disease probability in relation to catecholamine biochemistry and reason for disease suspicion. Eur. J. Endocrinol. 181(4), 409\u2013420 (2019). https:\/\/doi.org\/10.1530\/EJE-19-0159","journal-title":"Eur. J. Endocrinol."},{"issue":"4","key":"4698_CR31","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1111\/jch.14779","volume":"26","author":"W Zhang","year":"2024","unstructured":"W. Zhang, X. Li, W. Li, Y. Zhang, J. Cai, S. Feng et al., Clinical diagnosis of pheochromocytoma and paraganglioma-induced secondary hypertension through UPLC\u2010MS\/MS analysis of plasma catecholamines and their metabolites. J. Clin. Hypertens. 26(4), 416\u2013424 (2024). https:\/\/doi.org\/10.1111\/jch.14779","journal-title":"J. Clin. Hypertens."},{"issue":"2","key":"4698_CR32","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1507\/endocrj.EJ18-0407","volume":"66","author":"I Abe","year":"2019","unstructured":"I. Abe, H. Fujii, H. Ohishi, K. Sugimoto, M. Minezaki, M. Nakagawa, S. Takahara, T. Kudo, M. Abe, K. Ohe, T. Yanase, K. Kobayashi, Differences in the actions of adrenaline and noradrenaline with regard to glucose intolerance in patients with pheochromocytoma. Endocr. J. 66(2), 187\u2013192 (2019). https:\/\/doi.org\/10.1507\/endocrjEJ18-0407","journal-title":"Endocr. J."},{"issue":"6","key":"4698_CR33","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1210\/jc.2014-1498","volume":"99","author":"JWM Lenders","year":"2014","unstructured":"J.W.M. Lenders, Q.Y. Duh, G. Eisenhofer, A.P. Gimenez-Roqueplo, S.K.G. Grebe, M.H. Murad et al., Pheochromocytoma and Paraganglioma: An Endocrine Society Clinical Practice Guideline. J. Clin. Endocrinol. Metabolism. 99(6), 1915\u20131942 (2014). https:\/\/doi.org\/10.1210\/jc.2014-1498","journal-title":"J. Clin. Endocrinol. Metabolism"},{"issue":"5","key":"4698_CR34","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1210\/jc.2018-01707","volume":"104","author":"LM Gruber","year":"2019","unstructured":"L.M. Gruber, R.P. Hartman, G.B. Thompson, T.J. McKenzie, M.L. Lyden, B.M. Dy et al., Pheochromocytoma Characteristics and Behavior Differ Depending on Method of Discovery. J. Clin. Endocrinol. Metabolism. 104(5), 1386\u20131393 (2019). https:\/\/doi.org\/10.1210\/jc.2018-01707","journal-title":"J. Clin. Endocrinol. Metabolism"},{"issue":"2","key":"4698_CR35","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1530\/EJE-09-0384","volume":"161","author":"R Kopetschke","year":"2009","unstructured":"R. Kopetschke, M. Slisko, A. Kilisli, U. Tuschy, H. Wallaschofski, M. Fassnacht, M. Ventz, F. Beuschlein, M. Reincke, N. Reisch, M. Quinkler, Frequent incidental discovery of phaeochromocytoma: data from a German cohort of 201 phaeochromocytoma. Eur. J. Endocrinol. 161(2), 355\u2013 (2009). \u2013\u200961 https:\/\/doi.org\/10.1530\/EJE-09-0384","journal-title":"Eur. J. Endocrinol."},{"issue":"4","key":"4698_CR36","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.eprac.2025.12.005","volume":"32","author":"M LaRue","year":"2026","unstructured":"M. LaRue, C.A. Stratakis, A. Kalik, F.R. Faucz, T. Carling, Silent Pheochromocytoma Is an Underrecognized Clinical Entity: Results From a High-Volume Adrenal Surgery Hospital. Endocr. Pract. 32(4), 533\u2013539 (2026). 101016\/j.eprac202512005 https:\/\/doi.org\/10.1016\/j.eprac202512005","journal-title":"Endocr. Pract."},{"key":"4698_CR37","unstructured":"M. Araujo-Castro, C. M\u00ednguez Ojeda, R. Garc\u00eda Centeno, M.C. L\u00f3pez-Garc\u00eda, C. Lamas, F.A. Hanzu, M. Mora, Del M. Castillo Tous, P. Rodr\u00edguez de Vera G\u00f3mez, P. Parra Ram\u00edrez, C. Alvarez-Escola, C. Blanco Carrera, Barahona San Mill\u00e1n, R. Recasens, M. Vald\u00e9s, N. Gracia Gimeno, P. de Novoa, P. Vicente, A. Manj\u00f3n, L. Garc\u00eda Sanz, I. Michalopoulou, T. Calatayud, M. Glycemic disorders in patients with pheochromocytomas and sympathetic paragangliomas"},{"issue":"1","key":"4698_CR38","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1530\/EC-17-0321","volume":"7","author":"H Falhammar","year":"2018","unstructured":"H. Falhammar, M. Kjellman, J. Calissendorff, Initial clinical presentation and spectrum of pheochromocytoma: a study of 94 cases from a single center. Endocr. Connections. 7(1), 186\u2013192 (2018). https:\/\/doi.org\/10.1530\/EC-17-0321","journal-title":"Endocr. Connections"},{"issue":"6","key":"4698_CR39","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.jamcollsurg.2009.09.022","volume":"209","author":"MA Guerrero","year":"2009","unstructured":"M.A. Guerrero, J.M. Schreinemakers, M.R. Vriens, I. Suh, J. Hwang, W.T. Shen, J. Gosnell, O.H. Clark, Q.Y. Duh, Clinical spectrum of pheochromocytoma. J. Am. Coll. Surg. 209(6), 727\u2013732 (2009). https:\/\/doi.org\/10.1016\/j.jamcollsurg200909022","journal-title":"J. Am. Coll. Surg."},{"issue":"19","key":"4698_CR40","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1136\/heartjnl-2013-304073","volume":"99","author":"A Giavarini","year":"2013","unstructured":"A. Giavarini, A. Chedid, G. Bobrie, P.F. Plouin, A. Hag\u00e8ge, L. Amar, Acute catecholamine cardiomyopathy in patients with phaeochromocytoma or functional paraganglioma. Heart. 99(19), 1438\u20131444 (2013). https:\/\/doi.org\/10.1136\/heartjnl-2013-304073","journal-title":"Heart"},{"issue":"5","key":"4698_CR41","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1055\/s-0032-1306294","volume":"44","author":"T Zelinka","year":"2012","unstructured":"T. Zelinka, O. Petr\u00e1k, H. Turkov\u00e1, R. Holaj, B. Strauch, M. Kr\u0161ek, A.B. Vr\u00e1nkov\u00e1, Z. Musil, J. Du\u0161kov\u00e1, J. Kubinyi, D. Michalsk\u00fd, K. Nov\u00e1k, J. Widimsk\u00fd, High incidence of cardiovascular complications in pheochromocytoma. Horm. Metab. Res. 44(5), 379\u2013384 (2012). https:\/\/doi.org\/10.1055\/s-0032-1306294","journal-title":"Horm. Metab. Res."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-026-04698-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-026-04698-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-026-04698-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T06:12:59Z","timestamp":1783923179000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-026-04698-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,13]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4698"],"URL":"https:\/\/doi.org\/10.1007\/s12020-026-04698-1","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,13]]},"assertion":[{"value":"7 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}],"article-number":"226"}}